Dr. Kannan has more than 15 years of research experience in nanometal chemistry, bioconjugate chemistry, radionuclide chemistry, transition-metal chemistry, phosphorus chemistry, nanoscience and nanomedicine. He has published over 45 papers in peer-reviewed journals and is a principal inventor on over 15 patents and invention disclosures. Dr. Kannan is a recipient of a gold medal for best PhD thesis from the Indian Institute of Science, India.

Dr. Kannan currently serves as Editor-in-Chief for Cancer Nanotechnology: Basic, Clinical and Translation Research (Springer Publishers) http://www.springer.com/springerwiennewyork/chemistry/journal/12645. He is a founding editor for AZojono-Journal of Nanotechnology online and also Editor-in-Chief for Journal of Nanomedicine (Bentham Publishers). In addition, he also serves an Associate Editor for the International Journal of Green Nanotechnology and Synthesis, Reactivity in Inorganic and Nanometal Chemistry (Taylor and Francis).

Dr. Kannan’s research group is focused on developing nanoconjugates for selective delivery to desired sites or organs. He has developed novel pathways for the synthesis of multifunctional targeted gold nanoconstructs. He has also pioneered the development of biocompatible gold nanoparticles for applications in molecular imaging and therapy. Dr. Kannan, in collaboration with Dr. Katti and other scientists, has utilized gold nanoparticles for detecting prostate, breast and pancreatic cancer. His current research focus areas are: (i) Design and development of theranostic nanoconjugates for tumor detection, imaging and treatment; (ii) Development of novel nanoprobes for molecular imaging using CT modality; (iii) Development of multifunctional nanoconstructs for drug delivery in cancer therapy; and, (iv) Targeted radioactive nanoparticles for tumor therapy.